Srestha Mazumderprofile image

Srestha Mazumder


Current Appointments

Senior Clinical Research Officer
email hidden; JavaScript is required

Srestha Mazumder is a dedicated senior clinical research officer with a deep commitment to advancing our understanding of neurodegenerative diseases. With over seven years of experience in patient-facing clinical research, she has worked extensively with vulnerable patient groups, particularly those affected by Motor Neuron Disease (MND), Frontotemporal Dementia (FTD), and Alzheimer’s disease. Srestha is passionate about bridging the gap between clinical care and research.

Srestha holds a Bachelor of Psychological Science (Psychology) from the University of New South Wales and earned First-Class Honours in Neuroscience, completing her thesis at the Sydney Brain Bank under the supervision of Dr. Claire Shepherd.

Throughout her career, Srestha has led and coordinated numerous Phase II and III clinical trials, contributing to significant advancements in the understanding of neurodegenerative disorders. Her research has been widely published and reflects a commitment to exploring the intricacies of disease and their clinical manifestations.

Srestha’s research interests continue to evolve, centering on the complex interplay between brain pathology and clinical outcomes, as well as the cognitive, behavioural, and psychological changes seen in neurodegenerative diseases and their impact on patients’ and carers. Her broader research aims focus on enhancing the quality of life for patients with MND and FTD. Through her work, she seeks not only to deepen scientific understanding but also to provide meaningful improvements in patient care and support for their families.

Support this research

Publications

2024 Sep

Regional health priorities for dementia: a roadmap for the Western Pacific

View full journal-article on http://dx.doi.org/10.1016/j.lanwpc.2024.101179

2023, 13 Nov

Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis

View full journal-article on http://dx.doi.org/10.1186/s40478-023-01670-2

2023, 05 May

Short tandem repeat expansions in sporadic amyotrophic lateral sclerosis and frontotemporal dementia

View full journal-article on http://dx.doi.org/10.1126/sciadv.ade2044

2023, 01 Mar

Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis

View full journal-article on http://dx.doi.org/10.1093/brain/awac467

2022, 29 Dec

Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis

View full journal-article on http://dx.doi.org/10.1093/braincomms/fcac340

2022 Dec

The contribution of brain banks to knowledge discovery in amyotrophic lateral sclerosis: A systematic review

View full journal-article on https://doi.org/10.1111/nan.12845

2022, 14 Sep

Post-mortem brain histological examination in the substantia nigra and subthalamic nucleus in Parkinson’s disease following deep brain stimulation

View full journal-article on http://dx.doi.org/10.3389/fnins.2022.948523

2022 Aug

NEK1 and STMN2 short tandem repeat lengths are not associated with Australian amyotrophic lateral sclerosis risk

View full journal-article on http://dx.doi.org/10.1016/j.neurobiolaging.2022.04.012

2021, 25 Nov

Factors That Influence Non-Motor Impairment Across the ALS-FTD Spectrum: Impact of Phenotype, Sex, Age, Onset and Disease Stage

View full journal-article on http://dx.doi.org/10.3389/fneur.2021.743688